From 2019 CytoDyn Announces FDA Clearance to Pr
Post# of 148126
(Total Views: 553)
Posted On: 08/15/2022 11:13:59 PM
Re: chazzledazzle #127678
From 2019
Quote:
CytoDyn Announces FDA Clearance to Proceed with Phase 2 Study of Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer
https://www.globenewswire.com/news-release/20...ancer.html
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼